bioXXmed AG (XTER:T5O) Total Stockholders Equity : €21.11 Mil (As of Jun. 2023)

View and export this data going back to 2006. Start your Free Trial

What is bioXXmed AG Total Stockholders Equity?

bioXXmed AG's Total Stockholders Equity for the quarter that ended in Jun. 2023 was €21.11 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. bioXXmed AG's Book Value per Share for the quarter that ended in Jun. 2023 was €4.11. The ratio of a company's debt over equity can be used to measure how leveraged this company is. bioXXmed AG's Debt-to-Equity for the quarter that ended in Jun. 2023 was 0.00.

bioXXmed AG Total Stockholders Equity Historical Data

The historical data trend for bioXXmed AG's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

bioXXmed AG Total Stockholders Equity Chart

bioXXmed AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

13.51

17.75

21.93

17.87

21.42

bioXXmed AG Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Stockholders Equity	Get a 7-Day Free Trial															21.32	17.87	21.77	21.42	21.11

bioXXmed AG (XTER:T5O) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

bioXXmed AG's Book Value per Share for the quarter that ended in Jun. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(21.108	-	0)	/	5.1375
	=	4.11

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

bioXXmed AG's Debt-to-Equity for the quarter that ended in Jun. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	21.108
	=	0.00

bioXXmed AG Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of bioXXmed AG's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

bioXXmed AG (XTER:T5O) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » bioXXmed AG (XTER:T5O) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

T5O:Germany T5O:Germany

Address

Riedstrasse 2, Darmstadt, HE, DEU, 64295

Website

https://www.bioxxmed.ag

bioXXmed AG is an investment and holding company in the technology sector. It originated from CytoTools GmbH, a successful German technology enterprise from the pharmaceuticals and medical products field.

bioXXmed AG (XTER:T5O) Headlines

No Headlines